BlackRock Japan’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$17.2M Buy
207,324
+2,243
+1% +$186K 0.06% 365
2016
Q3
$19M Buy
205,081
+2,358
+1% +$218K 0.06% 337
2016
Q2
$15.8M Buy
202,723
+5,606
+3% +$436K 0.06% 370
2016
Q1
$16.3M Sell
197,117
-721
-0.4% -$59.5K 0.06% 343
2015
Q4
$20.7M Sell
197,838
-143
-0.1% -$15K 0.08% 288
2015
Q3
$20.9M Buy
197,981
+1,521
+0.8% +$160K 0.08% 271
2015
Q2
$26.9M Buy
196,460
+11,622
+6% +$1.59M 0.1% 226
2015
Q1
$23M Sell
184,838
-956
-0.5% -$119K 0.09% 255
2014
Q4
$16.8M Buy
185,794
+14,832
+9% +$1.34M 0.06% 340
2014
Q3
$12.3M Buy
170,962
+14,972
+10% +$1.08M 0.05% 385
2014
Q2
$9.7M Sell
155,990
-15,091
-9% -$939K 0.04% 460
2014
Q1
$11.7M Buy
171,081
+12,022
+8% +$820K 0.05% 405
2013
Q4
$11.2M Sell
159,059
-3,666
-2% -$258K 0.05% 421
2013
Q3
$11.7M Buy
162,725
+14,292
+10% +$1.03M 0.06% 392
2013
Q2
$8.27M Buy
+148,433
New +$8.27M 0.04% 495